Latest News and Press Releases
Want to stay updated on the latest news?
-
WINNIPEG, MANITOBA--(Marketwired - Sept. 23, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on September 22, 2015, it issued 254,178 common shares of the...
-
WINNIPEG, MANITOBA--(Marketwired - Aug. 21, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) ("Kane Biotech" or the "Company"), a biotechnology company engaged in the development and...
-
WINNIPEG, MANITOBA--(Marketwired - Aug. 4, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
-
WINNIPEG, MANITOBA--(Marketwired - July 28, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) ("Kane Biotech" or the "Company"), a biotechnology company engaged in the development and...
-
WINNIPEG, MANITOBA--(Marketwired - June 25, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on June 23, 2015, it issued 254,178 common shares of the...
-
WINNIPEG, MANITOBA--(Marketwired - June 25, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and...
-
WINNIPEG, MANITOBA--(Marketwired - May 13, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), is a biotechnology company engaged in the development and commercialization of products that prevent and...
-
WINNIPEG, MANITOBA--(Marketwired - May 11, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
-
WINNIPEG, MANITOBA--(Marketwired - March 26, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company developing and commercializing products that prevent and remove microbial...
-
WINNIPEG, MANITOBA--(Marketwired - March 24, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on March 23, 2015, it issued 248,605 common shares of the Corporation...